Please login to the form below

Not currently logged in
Email:
Password:

Frank Walters joins Frontera

Frontera London has appointed Frank Walters, former creative director at TBWA/Paling Walters as non-executive chairman

Frontera London has appointed Frank Walters, former creative director at TBWA/Paling Walters as non-executive chairman. It is the first of a number of senior appointments planned by the start-up.

Walters said: "Our ambition is to provide health with a much-needed, progressive approach – an approach that reminds everyone of the crucial role that creativity plays in tackling health challenges.

"We're building a talented team that hails from a range of backgrounds: consumer and healthcare, client as well as agency.

"For creative thinking to thrive, it has to be supported by a progressive, honest and collaborative culture. And we have to take the clients with us on that journey. But it starts by ensuring we offer our clients outstanding work."

Walters is a renowned director in health, both at a domestic and international level. He remains a judge at major awards, and he convened the panel at this year's IPA Awards.

Frontera combines its focus on the health consumer with its knowledge of the professional environment to deliver integrated solutions that simultaneously engage both audiences.

Managing partner Craig Mills commented on the appointment: "[We believe] in the principle that good ideas deliver the results that our clients seek. Having Frank on the team can only enhance our ability to achieve this."

10th May 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics